Jincort-GM Cream is a topical formulation containing Fluocinolone acetonide (0.01% w/w), Miconazole (2.0% w/w), and Neomycin (0.5% w/w), designed for the treatment of inflammatory and infectious dermatological conditions. Fluocinolone acetonide, a medium-potency corticosteroid, exerts anti-inflammatory, antipruritic, and vasoconstrictive effects, effectively reducing redness, swelling, and itching associated with dermatoses. Miconazole, an imidazole antifungal agent, provides broad-spectrum activity against dermatophytes, yeasts, and molds, inhibiting ergosterol synthesis and disrupting fungal cell membrane integrity. Neomycin, an aminoglycoside antibiotic, offers bactericidal activity primarily against Gram-negative organisms by inhibiting bacterial protein synthesis. The combination of these active ingredients in Jincort-GM Cream allows for simultaneous management of mixed infections involving fungal and bacterial pathogens alongside inflammatory skin conditions such as eczema, dermatitis, and secondary infected lesions. The cream base facilitates adequate skin penetration and local action with minimal systemic absorption. Jincort-GM Cream should be applied topically to the affected area as directed by a healthcare professional, avoiding prolonged use to minimize potential corticosteroid-related adverse effects. It is contraindicated in patients with hypersensitivity to any component and should be used cautiously in cases of viral or tubercular skin infections.